Buscar resultados de ensayos clínicos

Patrocinado por

Cytomegalovirus Infections - 8 Studies Found

Estado Estudiar
Completed Nombre del estudio: Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients
Condición: Cytomegalovirus Infection
Fecha: 2008-06-13
Intervenciones: Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings
Completed Nombre del estudio: Study of Prophylactic Vs Preemptive Valganciclovir
Condición: Cytomegalovirus Infection
Fecha: 2006-09-07
Intervenciones: Drug: Valganciclovir
Completed Nombre del estudio: Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
Condición: Cytomegalovirus Infections
Fecha: 2006-01-31
Intervenciones: Drug: Artesunate PO Artesunate
Completed Nombre del estudio: Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients
Condición: Cytomegalovirus Infections
Fecha: 2007-07-05
Intervenciones:
  • Drug: maribavir 100mg twice a

Completed Nombre del estudio: Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
Condición: Cytomegalovirus Infections
Fecha: 2006-12-12
Intervenciones:
  • Drug: maribavir 100 mg twice d
Completed Nombre del estudio: Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Condición: Cytomegalovirus Infections
Fecha: 2025-11-04
Intervenciones: Open label 480 mg given daily for 60 days
NOT_YET_RECRUITING Nombre del estudio: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
Condición: Cytomegalovirus Infections
Fecha: 2025-11-04
Intervenciones: Letermovir for CMV prophylaxis in thoracic organ transplant recipients.Letermovir will be administered by oral administration, as per study
COMPLETED Nombre del estudio: A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults
Condición: Cytomegalovirus Infections
Fecha: 2025-11-04
Intervenciones: Three doses of the candidate CMVsu vaccine consisting of a combination of low dose pentamer and low dose gB antigens, adjuvanted are administered intr